Dr. Rodriguez is a PGY-6 categorical general surgery resident pursuing a career in vascular surgery.  He has completed a 2 year post-doctoral research fellowship in the Harrison Department of Surgical Research at the University of Pennsylvania under the direction of Dr. Ali Naji. He studied B-lymphocyte tolerance after organ transplantation, as well as therapeutic strategies to prevent chronic allograft vasculopathy.

2007 - present

Assistant Instructor in Surgery

2010 - 2012

Postdoctoral Researcher

• Resident and Associate Society
• American College of Surgeons

1. Redfield RR, Parsons RF, Rodriguez E, Mustafa M, Cassuto J, Vivek K, Noorchashm H, Naji A, Levine MH, Abt PL. Underutilization of A2 ABO incompatible kidney transplantation. Clin Transplant. 2012 May-Jun;26(3):489-94.
2. Parsons RF, Redfield RR 3rd, Rodriguez E, Mustafa MM, Vivek K, Murayama M, Naji A, Noorchashm H. Primary B cell repertoire remodeling to achieve humoral transplantation tolerance. Semin Immunol. 2012 Apr;24(2):109-14.
3. Redfield RR 3rd, Rodriguez E, Parsons R, Vivek K, Mustafa MM, Noorchashm H, Naji A. Essential role for B cells in transplantation tolerance. Curr Opin Immunol. 2011 Oct;23(5):685-91.
4. Vivek K, Mustafa MM, Rodriguez E, Redfield RR 3rd, Parsons RF, Rostami S, Migone TS, Cancro MP, Naji A, Noorchashm H. Strategies for B-lymphocyte repertoire remodeling in transplantation tolerance. Immunol Res. 2011 Oct;51(1):1-4.
5. Rodriguez E, Ouma G, Muthumani K, Weiner D, Wilensky RL, MD, Mohler III ER. In Vivo Electroporation of Constitutively Expressed HIF-1α Plasmid DNA Improves Limb Perfusion, Salvage, and Functional Capacity in Mouse Model of Limb ischemia. Arterioscler Thromb Vasc Biol.—In Submission.

1. Rodriguez E, Rostami S, Mustafa M, Parsons R, Vivek K, Redfield R, Devalaraja S, Murayama M, Koeberlein B, Migone T, Cancro M, Naji A, Noorchashm H. BLyS Neutralization Abrogates Humoral Autoimmunity in a Chronic Heart Allograft Rejection Model. American Transplant Congress. 2012.
2. Rodriguez E, Redfield R, Luo Y, Mustafa M, Rostami S, Devalaraja S, Murayama M, Parsons R, Abt P, Noorchashm H, Naji A. Anti-IL-5 Immunotherapy Depletes Alloreactive Plasma Cells. American Transplant Congress. 2012.
3. Mustafa M, Vivek K, Ziaie A, Devalaraja S, Rostami S, Luo Y, Rodriguez E, Murayama M, Naji A. Inhibition of Autophagy Reduces Donor Specific Alloantibody in a Murine Skin-Allograft Model. American Transplant Congress. 2012.
4. Rodriguez E, Redfield RR, Vivek K, Mustafa MM, Naji A, Noorchashm H. Dysregulated B Lymphocyte Tolerance to Self-Antigens Results from Cardiac Allograft Rejection. American Transplant Congress. 2011.
5. Redfield RR, Parsons RF, Luo Y, Rostami S, Vivek K, Rodriguez E, Mustafa MM, Noorchashm H, Naji A, Abt PL. Bortezomib Alone Is Sufficient To Eliminate Plasma Cells and Donor-Specific Antibody in Mice. American Transplant Congress. 2011.
6. Redfield RR, Luo Y, Rostami S, Vivek K, Rodriguez E, Mustafa MM, Noorchashm H, Naji A, Abt PL., Parsons RF, RANKL-Directed Immunotherapy Reduces Donor Specific Antibodies in Sensitized Mice. American Transplant Congress. 2011.
7. Vivek K, Rostami S, Mustafa M, Rodriguez E, Redfield RR, Luo Y, Ziaie S, Parsons, RF, Migone TS, Cancro MP, Naji A, Noorchashm.H. B-Lymphocyte Directed Immunotherapy at the Time of Induction Is Insufficient for the Establishment of Humoral Transplantation Tolerance. American Transplant Congress. 2011.
8. Vivek K, Rostami S, Mustafa M, Rodriguez E, Redfield RR, Luo Y, Ziaie S, Parsons, RF, Migone TS, Cancro MP, Naji A, Noorchashm.H. BLyS-Directed Immunotherapy Purges Alloreactive Specificities from the Primary B-Cell Repertoire and Promotes Humoral Transplantation Tolerance. American Transplant Congress. 2011.